Diagnostic Testing for Breakthrough Bleeding One Week After Normal Menses
Begin with a pregnancy test (urine or serum β-hCG), followed by transvaginal ultrasound to evaluate for structural causes, and obtain thyroid-stimulating hormone (TSH) and complete blood count (CBC) to assess for systemic causes of abnormal uterine bleeding. 1
Initial Laboratory Testing
Essential First-Line Tests
Pregnancy test (β-hCG) is mandatory regardless of contraceptive use or reported menstrual history, as ectopic pregnancy and early pregnancy complications can present with intermenstrual bleeding 1
Complete blood count (CBC) should be obtained to assess for anemia from blood loss and evaluate platelet count, particularly important given that up to 20% of women with heavy menstrual bleeding have underlying inherited bleeding disorders 2
Thyroid-stimulating hormone (TSH) testing is recommended as thyroid dysfunction is a common reversible cause of ovulatory dysfunction and abnormal bleeding patterns 1, 3
Prolactin level should be measured when evaluating for ovulatory dysfunction, as hyperprolactinemia can cause irregular bleeding 1
Imaging Studies
Transvaginal Ultrasound as Primary Imaging
Transvaginal ultrasound (TVUS) combined with transabdominal approach is the first-line imaging modality to evaluate for structural causes including endometrial polyps, submucosal leiomyomas, adenomyosis, and endometrial pathology 4, 3
TVUS has pooled sensitivity and specificity of 82.5% and 84.6% respectively for adenomyosis, though detection may be limited when coexisting leiomyomas are present 4
Color Doppler should be incorporated as a standard component of pelvic ultrasound to evaluate internal vascularity and help distinguish endometrial polyps from other pathology, with specificity of 62-98% for polyp detection 4
Age-Specific Considerations for Endometrial Sampling
When to Perform Endometrial Biopsy
Women ≥35 years with recurrent anovulation require endometrial biopsy to exclude hyperplasia or malignancy due to prolonged unopposed estrogen exposure 3
Women <35 years with risk factors for endometrial cancer (obesity, PCOS with chronic anovulation, family history of Lynch syndrome) should undergo endometrial biopsy 3
Endometrial biopsy is preferred over dilation and curettage as it is less invasive, safer, and lower cost while maintaining adequate sensitivity for detecting endometrial hyperplasia or cancer 1
Additional Testing Based on Clinical Suspicion
Coagulation Studies
- Consider von Willebrand disease screening (von Willebrand factor antigen, ristocetin cofactor activity, factor VIII) in women with heavy bleeding since menarche, family history of bleeding disorders, or bleeding unresponsive to hormonal therapy 3, 2
Second-Line Imaging When Indicated
Advanced Evaluation for Focal Lesions
Saline infusion sonohysterography (hysterosonography) should be performed when TVUS demonstrates focal endometrial abnormality, as it provides superior characterization of intracavitary lesions 4, 3
Hysteroscopy is reserved for cases where medical treatment fails or when focal lesions are suspected but not adequately characterized by ultrasound, allowing direct visualization and directed biopsy 1, 3
MRI is not recommended as first-line imaging but may be useful for complex cases or when ultrasound findings are inconclusive 5
Clinical Pitfalls to Avoid
Do not rely on endometrial thickness alone in premenopausal women, as normal thickness varies with menstrual cycle phase and polyps or other pathology can be present even with thickness <5 mm 4
Cervical pathology must be excluded early with speculum examination and Pap smear according to screening guidelines, as cervical lesions can present with intermenstrual bleeding 5
Bleeding score assessment (such as pictorial blood assessment chart) can objectively quantify blood loss and help distinguish true menorrhagia from perceived heavy bleeding 6